Increased blood concentrations of interleukin-12 are associated with a longer survival in untreatable metastatic solid tumor patients: Preliminary observations

International Journal of Biological Markers

Volumn 12, Issue 3, 1997, Pages 125-127

  Lissoni, P ^a   Rovelli, F ^a   Fumagalli, L ^b   Mauri, E ^a   Barni, S ^a   Tancini, G ^a  

^a SAN GERARDO HOSPITAL   (Italy)

^b Chiron Company   (Italy)

Author keywords

Advanced cancer; Immunomodulation; Interlukin 12

Indexed keywords

INTERLEUKIN 12;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME IMMUNOASSAY; FEMALE; HUMAN; MALE; METASTASIS; PROGNOSIS; SOLID TUMOR;

EID: 0031473575     PISSN: 03936155     EISSN: None     Source Type: Journal    
DOI: 10.1177/172460089701200307     Document Type: Article

References (9)

1. Broder S, Muul L, Waidmann TA. Suppressor cells in neoplastic disease. J Natl Cancer Inst 1978; 61: 5-11.
2. Atzpodien J, Kirchner H. Cancer cytokines, and cytotoxic cells: interleukin-2 in the immunotherapy of human neoplasms. Klin Wochenschr 1990; 68: 1-11.
3. Wojtowicz-Praga S. Reversal of tumor-induced immunosuppression: a new approach to cancer therapy. J Immunother 1997; 20: 165-77.
4. Wanebo HJ, Pace R, Hargett S, Katz D, Sando J. Production of and response to interleukin-2 in peripheral blood lymphocytes of cancer patients. Cancer 1986; 57: 356-62.
5. Lissoni P, Barni S, Rovelli F, Tancini G. Lower survival in metastatic cancer patients with reduced interleukin-2 blood concentrations. Preliminary report. Oncology 1991; 48: 125-7.
6. Banks RE, Patel PM, Selby PJ. Interleukin 12: a new clinical player in cytokine therapy. Br J Cancer 1995; 71: 655-9.
7. Lissoni P, Rovelli F, Pittalis S, Casati M, Perego MS, Grassi MG, Brivio F, Fumagalli L. Interleukin-12 in early or advanced cancer patients. Eur J Cancer, in press.
8. Lissoni P, Fumagalli L, Di Felice G, Mengo S, Mauri E, Merlini D, Meregalli S, Rovelli F, Barni S, Tancini G. Prognostic significance of changes in IL-12 secretion during cancer immunotherapy with EL-2: preliminary considerations. Int J Immunother, in press.
9. Romani N, Reider D, Heuer M, Ebner S, Kampgen E, Eibl B, Niederwieser D, Schuler G. Generation of mature dendritic cells from human blood. J Immunol Methods 1996; 196: 137-51.